U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Reduced hepatic N-acetylglutamate synthase activity

MedGen UID:
1054381
Concept ID:
CN376674
Finding
HPO: HP:6000161

Definition

Concentration or activity of N-acetylglutamate synthase in liver tissue below the lower limit of normal. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVReduced hepatic N-acetylglutamate synthase activity

Conditions with this feature

Hyperammonemia, type III
MedGen UID:
120649
Concept ID:
C0268543
Disease or Syndrome
N-acetylglutamate synthase deficiency (NAGSD) is an autosomal recessive disorder of the urea cycle. The clinical and biochemical features of the disorder are indistinguishable from carbamoyl phosphate synthase I deficiency (237300), since the CPS1 enzyme (608307) has an absolute requirement for NAGS (Caldovic et al., 2007).

Recent clinical studies

Clinical prediction guides

Aires CC, van Cruchten A, Ijlst L, de Almeida IT, Duran M, Wanders RJ, Silva MF
J Hepatol 2011 Aug;55(2):426-34. Epub 2010 Dec 13 doi: 10.1016/j.jhep.2010.11.031. PMID: 21147182

Supplemental Content

Table of contents

    Clinical resources

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...